Modulation response to checkpoint inhibitor treatment immunomodulatory combinations, methylation treatment and the role of chemotherapy

Date 10 October 2016
Event ESMO 2016 Congress
Session ESMO Colloquium - Immune checkpoint inhibition and chemotherapy in NSCLC and breast cancer: A Flamenco or a Tango?
Presenter Johan Vansteenkiste
Authors J.F. Vansteenkiste
  • Respiratory Oncology Unit - Department Respiratory Diseases, University Hospitals KU Leuven, 3000 - Leuven/BE